NewsRoom Articles - Page 40 of 154 - PsychedelicNewsWire (PNW)

MondayJan 23, 2023 1:44 pm

Nonprofit in Oregon Launches Training Program for Psilocybin Facilitators

Oregon became the first state in the United States to allow psychedelic use after it legalized the use of psilocybin by adults in 2020. A psychedelic compound that occurs in magic mushrooms, psilocybin is one of many other psychedelics that are said to have immense potential as effective mental-health treatments. Initial studies have shown that psilocybin may be able to alleviate the symptoms of mental health conditions, including anxiety, depression and substance-use disorder, especially when paired with psychotherapy. Generally, psychedelic-assisted therapy involves undergoing a psychedelic experience under a trained physician followed by several hours of counseling to teach the patient…

FridayJan 20, 2023 11:22 am

Debate Over the Use of Apps in Psychedelic Therapy Grows

With at least one in five Americans said to experience mental illness at least once a year and more than 2.7 million youth suffering from severe major depression, interest in safe and effective mental health treatments is at an all-time high. Initial research has uncovered that psychedelics such as MDMA, psilocybin and ketamine may be able to mitigate the symptoms of conditions, including depression, post-traumatic stress disorder and eating disorders. As such, pharmaceutical companies, institutional investors and billionaires are pouring millions of dollars into the development of psychedelic-assisted therapies. To ostensibly reduce the burden on healthcare professionals and make psychedelic-assisted…

ThursdayJan 19, 2023 12:20 pm

Legislators in Washington File Measure to Legalize Magic Mushrooms

Washington state may be one step closer to launching a legal market for magic mushrooms after bipartisan senators filed a bill to legalize psychedelic mushrooms this year. Lawmakers first introduced an earlier version of the psilocybin legalization bill in January 2022, but it had fewer cosponsors and failed to get any traction. Senator Jesse Salomon reintroduced the legislation last week, unveiling a revised version of the bill with 20 cosponsors. The bill seeks to legalize magic mushrooms in Washington and regulate a psilocybin market for adults aged 21 and older. According to language from the revised bill, its objective is…

WednesdayJan 18, 2023 11:52 am

States Pursuing Psychedelic Reform in 2023

Legislators in various states in the country are working to advance psychedelic reform during the 2023 session. The proposals introduced range from the decriminalization of natural plants and fungi to the legalization of psilocybin for therapeutic use. Below is an overview of some of the measures lawmakers plan to advance in their respective jurisdictions. Connecticut Rep. David Michel recently introduced a psychedelics measure that would legalize the use of psilocybin for therapeutic and medicinal purposes. In a recent phone interview, Michel explained that the decriminalization of these substances would stop certain communities from being targeted, adding that nature-based approaches had…

TuesdayJan 17, 2023 1:31 pm

Study Finds Ethnicity, Race Linked to Mental Health Outcomes and Psychedelic Use

Psychedelics have become popular in the recent times, with growing evidence showing that the substances may be beneficial in the treatment of mental health disorders such as anxiety and depression. One such study found that the administration of psychedelics was linked to significant improvements in anxiety and depression symptoms as well as increased emotional well-being. Now, a new study has discovered that ethnicity and race moderate the link between major depressive episodes and the use of psychedelic drugs. Grant M. Jones, a Harvard University clinical psychology PhD student and the author of the study, revealed that the main objective was…

FridayJan 13, 2023 11:15 am

Colorado to Appoint Psychedelics Advisory Board Members as State Implements Ballot Measure Provisions

Officials in Colorado are seeking people to join its first psychedelics advisory board, which will inform the state on how to implement psychedelics legalization after voters approved a reform measure on last year’s ballot. The state’s Department of Regulatory Agencies has provided a web page where individuals can fill out applications to be considered. Applicants will be required to provide information on their basic background and qualifications. The Natural Medicine Advisory Board will have 15 members, all of whom will be appointed by Governor Jared Polis. The board members will be responsible for ensuring that research is conducted on psychedelics…

ThursdayJan 12, 2023 1:51 pm

Tips for Talking to Your Teenagers About Psychedelics

Psychedelics have become increasingly popular, with more studies finding that the substances may have therapeutic benefits for a range of mental health disorders. While this is positive, their adoption into mainstream media also increases the risk of teens consuming these drugs in the name of experimentation. For example, data from a 2021 survey conducted by the University of Michigan found that roughly 10% of 8th graders, 19% of 10th graders and more than 30% of 12th graders has used illegal drugs in the last year. A separate survey by NIDA also found that a percentage of teens had consumed MDMA,…

ThursdayJan 12, 2023 9:00 am

Silo Pharma Inc. (NASDAQ: SILO) Provides Positive Update on Ongoing Study into the Use of Joint Homing Peptides as an Alternative Treatment for Rheumatoid Arthritis

Silo Pharma recently provided an update on an ongoing study delving into the potential use of SPU-21 joint homing peptides as an alternative treatment for rheumatoid arthritis The study, which is being carried out in conjunction with the University of Maryland, Baltimore, has resulted in positive initial results Since its founding, Silo Pharma has rapidly gained a reputation for its innovative approach towards seeking solutions to address a variety of underserved medical conditions Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused around merging traditional therapeutics with psychedelic research, recently revealed the positive interim data from its dose optimization…

WednesdayJan 11, 2023 10:38 am

Second MAPS Phase 3 Clinical Trial Confirms Positive MDMA Results

A growing body of research has revealed that psychedelic drugs such as psilocybin and MDMA have the potential to alleviate a variety of mental illnesses. Decades of federal prohibition made it nigh impossible for scientists to research the possible medical applications of psychedelics, but there has been an upsurge in psychedelic research over the past couple of years. Early results have been extremely encouraging, with clinical studies finding that psychedelics can cause profound changes in mental health and perception when paired with psychotherapy. The Multidisciplinary Association For Psychedelic Studies (MAPS) is at the helm of the first-ever phase 3 clinical…

TuesdayJan 10, 2023 1:33 pm

Ketamine, Smiling Faces Combo Hold Promise in Treating Depression

Early research and clinical trials have revealed that psychedelics can have significant mental health benefits when paired with psychotherapy. Researchers have found that hallucinogenic drugs such as ketamine and psilocybin can be effective against severe mental illnesses, including post-traumatic stress disorder, depression and eating disorders. Furthermore, psychedelic drugs deliver these benefits without the side effects that are often seen in pharmaceutical medications. Given that the field of psychedelic research is largely in its infancy, researchers across the world are still studying psychedelic drugs and trying to figure out how to implement them in mental health therapies. A recently published study…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000